Our AI creates a digital twin for every ICU patient, predicting life-threatening complications hours before they occur.
Reduce hypoglycemia by 98.6%, cut clinical burden by 35%, and free your team to focus on what matters most.
98.6%
Hypoglycemia Reduction
35%
Time Saved
80%
Glycemia in Target
Real data from real ICU patients. Our AI doesn't just optimize care protocols, it prevents harm through precision medicine.
From 7 in 100 patients to just 1 in 1,000. Our AI predicts severe hypoglycemic events to prevent severe harm from insulin.
Glucomeo™ automates protocol calculations and monitoring, freeing your ICU team to focus on complex clinical decisions and patient care.
Average ICUs achieve less than 45% time in glycemic target. By forecasting patient-specific glucose trajectories, time in target is almost doubled. Let the AI assist you when every decision counts.
From 7 in 100 patients experiencing severe hypoglycemia to just 1 in 1,000, real data from real ICUs.
Our AI builds a digital twin for each ICU patient, learning their unique metabolic response in real-time. The result? Precision medicine that predicts and prevents complications, giving clinical teams the insights they need to optimize care.
No two patients metabolize the same way. Our AI learns each patient's unique physiology and predicts their individual risk profile and glycemic trajectories, not population averages.
Up to 4-hour advance warnings for hypoglycemia and hyperglycemia. Enough time to adjust treatment, not scramble to respond.
Glucomeo™ eliminates 98.6% of severe hypoglycemic events. We don't just reduce risk, we virtually eliminate it.
Our latest peer-reviewed study demonstrated 80% glycemic control within the normoglycemic target range, based on data from 1,085 ICU patients and 86,010 hours of monitoring. Outcomes your clinical team can trust.
AI-powered solutions that prevent complications, reduce workload, and improve patient outcomes
Insulin Therapy
Severe hypoglycemia affects 7% of ICU patients, often leading to worsened outcomes and prolonged stays. Glucomeo™ reduces this to 0.1% by predicting glucose trajectories up to 4 hours in advance. Your team gets early warnings and recommendations, not emergencies.
Nutrition Therapy
Nutrition therapy isn't one-size-fits-all. Nutromeo™ personalizes feeding strategies based on each patient's metabolic response, optimizing recovery while minimizing complications.
Mechanical Ventilation
Coming soon: AI-powered mechanical ventilation management to optimize respiratory support for ICU patients.
Let's discuss your clinical needs
Whether you're interested in a demo, have questions about our solutions, or want to discuss how we can help your ICU, we're here to help.
Send us an Email